Legislation that would mandate the publication of the results of clinical
trials in a publicly accessible clinical trials database was introduced July
1 in the House of Representatives.
The Fair Access to Clinical Trials Act would require the sponsors of
publicly and privately funded studies of drugs, biologics, or medical devices
to register in a database that builds on the National Library of Medicine’s
online database (http://www.clinicaltrials.gov). It would also
require the sponsors to provide basic information about the study before it
begins, allow public access to the results, and authorize the imposition of
penalties on those who do not comply.
Kuehn BM. Trials on the Record. JAMA. 2005;294(6):673. doi:10.1001/jama.294.6.673-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: